Skip to main content
SpringerLink
Log in

Myeloablative Regimens Containing High Dose Etoposide Followed by Allogeneic or Autologous Bone Marrow Transplantation for Hematologic Malignancies

  • Conference paper
Acute Leukemias IV

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 36))

  • 73 Accesses

Abstract

Preparatory regimens administered prior to marrow transplantation are intended to eradicate the underlying malignancy and to immunosuppressive the host to allow durable engraftment. The latter is only required for allogeneic marrow graft recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. O’Dwyer PJ, Leyland-Jones B, Alonso MT, Marsoni S, Wittes RE(1985)Etoposide (VP-16-213). Current status of an active anticancer drug. New Engl. J Med 312: 692–700

    Article  PubMed  Google Scholar 

  2. Blume KG, Forman SJ, O’Donnell MR, Doroshow JH, Krance RA, Nademanee AP, Snyder DS, Schmidt GM, Fahey JL, Metter GE. Hill LR Findley DO, Sniecinski IJ (1987) Total body irradiation and high-dose etoposide: A new preparatory regimen for bone marrow trasplantation in patients with advanced hematologic malignancies. Blood 69: 10152–1020

    Google Scholar 

  3. Blume KG, Forman SJ (1987) High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignancies. Blut 55: 49–53

    Article  PubMed  CAS  Google Scholar 

  4. Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Kwak LW, Long GD, Stallbaum B, O’Connor P, Blume KG (1991) The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin’s disease and non-Hodgkin’s lymphoma: Preliminary data. Ann Oncol 2, Suppl 1: 47–50

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanford University Medical Center, 300 Pasteur Drive, Room H1353, Stanford, 94305, CA, USA

    K. G. Blume

Authors
  1. K. G. Blume
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. S. Snyder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. J. Chao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. J. Forman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, Germany

    T. Büchner

  2. Department of Pediatrics, University of Münster, Albert-Schweitzer-Strasse 33, 48145, Münster, Germany

    G. Schellong  & J. Ritter  & 

  3. Department of Internal Medicine, University of Göttingen, Robert-Koch-Strasse 40, 37075, Göttingen, Germany

    W. Hiddemann  & B. Wörmann  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Blume, K.G., Snyder, D.S., Chao, N.J., Forman, S.J. (1994). Myeloablative Regimens Containing High Dose Etoposide Followed by Allogeneic or Autologous Bone Marrow Transplantation for Hematologic Malignancies. In: Büchner, T., Hiddemann, W., Wörmann, B., Schellong, G., Ritter, J. (eds) Acute Leukemias IV. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78350-0_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78350-0_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78352-4

  • Online ISBN: 978-3-642-78350-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation